Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice by Fang Lv, Xiaoling Cai, Chu Lin, Wenjia Yang, Linong Ji

Subjects: “…GLP-1 receptor agonists…”
Get full text

Glucagon-like peptide 1 receptor agonists: A new approach to type 2 diabetes management by Lynn Lambert

Subjects: Get full text

The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome: A Narrative Review by Kamil Turlej, Dmytro Kowalczuk, Viktoryia Kasianik, Darya Lazitskaya, Mykola Sobchynskyi, Valeryia Milasheuskaya, Andrii Myrnyi, Iga Kiełbaszewska, Natallia Surosz, Katsiaryna Miraniuk

Subjects: Get full text

A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia by Luigi Vetrugno, Cristian Deana, Andrea Da Porto, Enrico Boero, Valentina Bellini, Daniele Guerino Biasucci, Elena Giovanna Bignami

Subjects: “…GLP-1 receptor agonists…”
Get full text

Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma by Zaynab A. Mouhammad, Anne Rombaut, Mariana Yolotzin García Bermúdez, Rupali Vohra, James R. Tribble, Pete A. Williams, Miriam Kolko

Subjects: Get full text

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation by Giulia Migliorisi, Giulia Migliorisi, Roberto Gabbiadini, Arianna Dal Buono, Matteo Ferraris, Matteo Ferraris, Giuseppe Privitera, Giuseppe Privitera, Lorenzo Petronio, Lorenzo Petronio, Peter Bertoli, Peter Bertoli, Cristina Bezzio, Cristina Bezzio, Alessandro Armuzzi, Alessandro Armuzzi

Subjects: Get full text

Novel antidiabetic therapies in patients with peripheral artery disease: current perspective by Miodrag Janić, Miodrag Janić, Miodrag Janić, Viviana Maggio, Andrej Janež, Andrej Janež, Manfredi Rizzo, Manfredi Rizzo

Subjects: Get full text

The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort by Eman A. Toraih, Awwad Alenezy, Mohammad H. Hussein, Shahmeer Hashmat, Saitej Mummadi, Nawaf Farhan Alrawili, Ahmed Abdelmaksoud, Manal S. Fawzy

Subjects: “…GLP-1 receptor agonists…”
Get full text

Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Mechanisms, Efficacy, and Safety by Michał Stasiak, Wiktor Żyro, Karolina Woźniak, Katarzyna Żyro, Franciszek Glapiński, Adam Woźniak

Subjects: “…GLP-1 receptor agonists…”
Get full text

Suboptimal physician adherence to evidence‐based guidelines for managing cardiorenal comorbidities in diabetes care: A retrospective single‐center study in Taiwan by Zong‐Yu Shen, Horng‐Yih Ou

Subjects: “…SGLT2 inhibitors and GLP‐1 receptor agonists…”
Get full text

Revisiting the role of novel weight management medications and bariatric surgery by LIANG Hui

Subjects: “…bariatric surgery|glp-1 receptor agonists|incretin|semaglutide|tirzepatide|obesity…”
Get full text

The potential adverse effects of hypodermic glucagon‐like peptide ‐1 receptor agonist on patients with type 2 diabetes: A population‐based study by Zhiyuan Cheng, Shuang Wang, Fu‐rong Li, Cheng Jin, Chunbao Mo, Jing Zheng, Xia Li, Fengchao Liang, Jinkui Yang, Dongfeng Gu

Subjects: Get full text

Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes by Bethany Murphy, Simran Chahal, Elleigh Shepherd, Nicole Taylor, Austin Camp

Subjects: Get full text

The Impact of GLP-1 Receptor Agonists on Women's Reproductive Health: A Review by Marta Wolszczak, Hanna Wołodkiewicz, Jakub Szmit

Subjects: Get full text

Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide by Larissa Dăniluc, Adina Braha, Oana Elena Sandu, Carina Bogdan, Loredana Suhov, Lina Haj Ali, Alexandra-Iulia Lazăr-Höcher, Alexandra Sima, Adrian Apostol, Mihaela Viviana Ivan

Subjects: Get full text

Are GLP-1 Analogues a New Solution for the Treatment of NAFLD? by Maria Sudoł, Katarzyna Dąbek, Michał Ochwat, Martyna Piekarska, Anna Skowronek, Aleksandra Kajtel, Gabriela Mierzwa, Zofia Sudoł

Subjects: “…MAFLD, NAFLD, GLP‐1 receptor agonists, GLP‐1 analogues, incretin mimetics.…”
Get full text

REBOUND OBESITY AFTER GLP-1 AGONISTS DISCONTINUATION by Zainab M. Al-Shammaa, Heba M. Attash, Luma Al-Obaidy

Subjects: “…glp-1 receptor agonists, weight regain, rebound obesity, discontinuation, lifestyle interventions…”
Get full text

Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review by Aleksander Jentkiewicz, Esmail Haj Obeid, Jakub Ulrych, Jan Krupa, Maciej Malinowski, Michał Krasowski, Alicja Kalinowska, Wiktoria Pietras, Adrian Kozieł, Zofia Kurek

Subjects: Get full text

The relative risk of clinically relevant cholelithiasis among glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus, real-world study by Mohammed Ali Gameil, Elshahat Ali Ahmed Mohamed Yousef, Rehab Elsayed Marzouk, Mohamed H. Emara, Abeer H. Abdelkader, Rasha Ibrahim Salama

Subjects: “…GLP1-receptor agonists…”
Get full text

Pasireotide-induced hyperglycemia in Cushing’s disease and Acromegaly: A clinical perspective and algorithms proposal by Przemysław Witek, Marek Bolanowski, Adam Krętowski, Aleksandra Głowińska

Subjects: Get full text